Hypera Future Growth
Future criteria checks 2/6
Hypera is forecast to grow earnings and revenue by 12% and 9.1% per annum respectively. EPS is expected to grow by 10.7% per annum. Return on equity is forecast to be 16.3% in 3 years.
Key information
12.0%
Earnings growth rate
10.7%
EPS growth rate
Pharmaceuticals earnings growth | 23.6% |
Revenue growth rate | 9.1% |
Future return on equity | 16.3% |
Analyst coverage | Good |
Last updated | 05 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 9,782 | 2,273 | 2,082 | 3,195 | 10 |
12/31/2025 | 8,442 | 1,673 | 2,431 | 2,738 | 12 |
12/31/2024 | 7,732 | 1,505 | 1,929 | 2,150 | 12 |
6/30/2024 | 8,001 | 1,693 | 1,903 | 2,620 | N/A |
3/31/2024 | 8,043 | 1,704 | 1,803 | 2,574 | N/A |
12/31/2023 | 7,915 | 1,649 | 1,581 | 2,396 | N/A |
9/30/2023 | 8,189 | 1,772 | 1,247 | 2,118 | N/A |
6/30/2023 | 8,086 | 1,741 | 1,157 | 2,072 | N/A |
3/31/2023 | 7,751 | 1,694 | 1,160 | 2,029 | N/A |
12/31/2022 | 7,546 | 1,705 | 529 | 2,039 | N/A |
9/30/2022 | 7,051 | 1,640 | 205 | 1,825 | N/A |
6/30/2022 | 6,648 | 1,636 | 91 | 1,688 | N/A |
3/31/2022 | 6,260 | 1,660 | -29 | 1,560 | N/A |
12/31/2021 | 5,937 | 1,618 | 494 | 1,399 | N/A |
9/30/2021 | 5,446 | 1,577 | 583 | 1,293 | N/A |
6/30/2021 | 4,902 | 1,462 | -798 | 1,218 | N/A |
3/31/2021 | 4,445 | 1,382 | -805 | 1,163 | N/A |
12/31/2020 | 4,089 | 1,322 | -749 | 1,183 | N/A |
9/30/2020 | 3,883 | 1,243 | -759 | 1,125 | N/A |
6/30/2020 | 3,803 | 1,165 | 497 | 959 | N/A |
3/31/2020 | 3,726 | 1,106 | 387 | 803 | N/A |
12/31/2019 | 3,295 | 1,189 | 462 | 824 | N/A |
9/30/2019 | 3,294 | 1,252 | 563 | 853 | N/A |
6/30/2019 | 3,233 | 1,225 | 610 | 855 | N/A |
3/31/2019 | 3,180 | 1,164 | 775 | 1,005 | N/A |
12/31/2018 | 3,724 | 1,135 | 846 | 1,066 | N/A |
9/30/2018 | 3,789 | 1,288 | 896 | 1,108 | N/A |
6/30/2018 | 3,716 | 1,251 | 771 | 981 | N/A |
3/31/2018 | 3,613 | 1,200 | N/A | 943 | N/A |
12/31/2017 | 3,500 | 1,111 | N/A | 933 | N/A |
9/30/2017 | 3,291 | 819 | N/A | 903 | N/A |
6/30/2017 | 3,226 | 795 | N/A | 950 | N/A |
3/31/2017 | 3,216 | 743 | N/A | 868 | N/A |
12/31/2016 | 3,228 | 647 | N/A | 882 | N/A |
9/30/2016 | 3,202 | 557 | N/A | 828 | N/A |
6/30/2016 | 3,129 | 432 | N/A | 683 | N/A |
3/31/2016 | 3,046 | 349 | N/A | 518 | N/A |
12/31/2015 | 2,957 | 345 | N/A | 324 | N/A |
9/30/2015 | 1,589 | 263 | N/A | 330 | N/A |
6/30/2015 | 2,039 | 326 | N/A | 430 | N/A |
3/31/2015 | 2,447 | 360 | N/A | 556 | N/A |
12/31/2014 | 2,768 | 338 | N/A | 664 | N/A |
9/30/2014 | 4,498 | 400 | N/A | 705 | N/A |
6/30/2014 | 4,423 | 357 | N/A | 698 | N/A |
3/31/2014 | 4,359 | 249 | N/A | 652 | N/A |
12/31/2013 | 4,259 | 259 | N/A | 666 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HYPM.Y's forecast earnings growth (12% per year) is above the savings rate (2.6%).
Earnings vs Market: HYPM.Y's earnings (12% per year) are forecast to grow slower than the US market (15.4% per year).
High Growth Earnings: HYPM.Y's earnings are forecast to grow, but not significantly.
Revenue vs Market: HYPM.Y's revenue (9.1% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: HYPM.Y's revenue (9.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HYPM.Y's Return on Equity is forecast to be low in 3 years time (16.3%).